ELIFE Holdings (00223) plans to discount approximately 17.07% for the sale of up to 271 million shares, raising approximately HK$271.33 million.

ELIFE HLDGS (00223) announced that on January 9, 2026, the company entered into a placement agreement with the placing agent. The placing agent will distribute up to 271 million new shares to a minimum of 6 placees at a placement price of HK$0.102 per share. The placement shares will be issued based on the general mandate granted to directors at a special general meeting of shareholders, representing approximately 16.67% of the total issued shares after the placement. The total nominal value of the placement shares at the maximum number is HK$27.12 million. The placement price of HK$0.102 represents a discount of approximately 17.07% compared to the closing price of HK$0.123 per share on the date of the placement agreement. Assuming all placement shares are successfully placed by the placing agent, the estimated total proceeds from the placement are approximately HK$27.664 million, with an estimated net proceeds of approximately HK$27.13 million intended for the development of the group's supply chain business, repayment of certain outstanding payables (including professional fees and loans), and supplementing the group's working capital.